Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 39 results.
User Information
Export Records
  1. 1.   CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
  2. Brault, Julie; Liu, Taylor; Liu,Siyuan; Lawson, Amanda; Choi, Uimook; Kozhushko, Nikita; Bzhilyanskaya, Vera; Pavel-Dinu, Mara; Meis, Ronald J; Eckhaus, Michael A; Burkett,Sandra; Bosticardo, Marita; Kleinstiver, Benjamin P; Notarangelo, Luigi D; Lazzarotto, Cicera R; Tsai, Shengdar Q; Wu, Xiaolin; Dahl, Gary A; Porteus, Matthew H; Malech, Harry L; De Ravin, Suk See
  3. Frontiers in Immunology. 2023, Jan 4; 13: 1067417.
  1. 2.   Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System
  2. Gardner, Cameron L; Pavel-Dinu, Mara; Dobbs, Kerry; Bosticardo, Marita; Reardon, Paul K; Lack,Justin; DeRavin, Suk See; Le, Kent; Bello, Ezekiel; Pala, Francesca; Delmonte, Ottavia M; Malech, Harry; Montel-Hagan, Amelie; Crooks, Gay; Acuto, Oreste; Porteus, Matthew H; Notarangelo, Luigi D
  3. Journal of Clinical Immunology. 2021, Jul;
  1. 3.   Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection
  2. Annamalai, Thavamathi; Lu,Zhongyan; Jung, Kwonil; Langel, Stephanie N.; Tuggle, Christopher K.; Dekkers, Jack C. M.; Waide, Emily H.; Kandasamy, Sukumar; Saif, Linda J.
  3. VIRUS RESEARCH. 2019, Jul 2; 267: 21-25.
  1. 4.   Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin
  2. Kim, So Young; Zhang, Fuming; Gong, Wang; Chen, Keqiang; Xia, Kai; Liu, Fei; Gross, Richard A; Wang, Jiming; Linhardt, Robert J; Cotten, Myriam L
  3. Journal of Biological Chemistry. 2018, Oct 5; 293(40): 15381-15396.
  1. 5.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 6.   Isolation, Structural Elucidation, and Absolute Stereochemistry of Enigmazole A, a Cytotoxic Phosphomacrolide from the Papua New Guinea Marine Sponge Cinachyrella enigmatica
  2. Oku, N.; Takada, K.; Fuller, R. W.; Wilson, J. A.; Peach, M. L.; Pannell, L. K.; McMahon, J. B.; Gustafson, K. R.
  3. Journal of the American Chemical Society. 2010, Aug; 132(30): 10278-10285.
  1. 7.   Therapeutic agents from the sea: biodiversity, chemo-evolutionary insight and advances to the end of Darwin's 200th year
  2. Newman, D. J.; Cragg, G. M.; Battershill, C. N.
  3. Diving and Hyperbaric Medicine. 2009, Dec; 39(4): 216-225.
  1. 8.   Self-inactivating Retroviral Vector-mediated Gene Transfer Induces Oncogene Activation and Immortalization of Primary Murine Bone Marrow Cells
  2. Bosticardo, M.; Ghosh, A.; Du, Y.; Jenkins, N. A.; Copeland, N. G.; C, otti
  3. Molecular Therapy. 2009 17(11): 1910-1918.
  1. 9.   Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
  2. Clement, J. A.; Kitagaki, J.; Yang, Y.; Saucedo, C. J.; O'Keefe, B. R.; Weissman, A. M.; Mckee, T. C.; McMahon, J. B.
  3. Bioorganic & Medicinal Chemistry. 2008 16(23): 10022-10028.
  1. 10.   Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy
  2. Hai, M.; Adler, R.; Bauer, T. R.; Tuschong, L. M.; Gu, Y. C.; Wu, X.; Hickstein, D. D.
  3. Gene Therapy. 2008 15(14): 1067-1071.
  1. 11.   Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR
  2. Yao, X. H.; Ping, Y. F.; Chen, J. H.; Xu, C. P.; Chen, D. L.; Zhang, R.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2008 215(4): 369-376.
  1. 12.   Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models
  2. Varticovski, L.; Hollingshead, M. G.; Robles, A. I.; Wu, X. L.; Cherry, J.; Munroe, D. J.; Lukes, L.; Anver, M. R.; Carter, J. P.; Borgel, S. D.; Stotler, H.; Bonomi, C. A.; Nunez, N. P.; Hursting, S. D.; Qiao, W. H.; Deng, C. X. X.; Green, J. E.; Hunter, K. W.; Merlino, G.; Steeg, P. S.; Wakefield, L. M.; Barrett, J. C.
  3. Clinical Cancer Research. 2007, Apr; 13(7): 2168-2177.
  1. 13.   Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas
  2. Lo, P. H. Y.; Leung, A. C. C.; Xiong, W. J.; Law, S.; Duh, F. M.; Lerman, M. I.; Stanbridge, E. J.; Lung, M. L.
  3. Cancer Letters. 2006, Mar; 234(2): 184-192.
  1. 14.   CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques
  2. Teleshova, N.; Kenney, J.; Williams, V.; Van Nest, G.; Marshall, J.; Lifson, J. D.; Sivin, I.; Dufour, J.; Bohm, R.; Gettie, A.; Pope, M.
  3. Journal of Leukocyte Biology. 2006, Feb; 79(2): 257-267.
  1. 15.   Retroviral transduction of IL-7R alpha into IL-7R alpha(-/-) bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia
  2. Jiang, Q.; Li, W. Q.; Aiello, F. B.; Klarmann, K.; Keller, J. R.; Durum, S. K.
  3. Gene Therapy. 2005, DEC; 12(24): 1761-1768.
  1. 16.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 17.   Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C
  2. Li, F.; Wang, F.; Haraldson, K.; Protopopov, A.; Duh, F. M.; Geil, L.; Kuzmin, I.; Minna, J. D.; Stanbridge, E.; Braga, E.; Kashuba, V. I.; Klein, G.; Lerman, M. I.; Zabarovsky, E. R.
  3. Cancer Research. 2004, SEP 15; 64(18): 6438-6443.
  1. 18.   Investigations of the marine flora and fauna of the Islands of Palau
  2. Faulkner, D. J.; Newman, D. J.; Cragg, G. M.
  3. Natural Product Reports. 2004 21(1): 50-76.
  1. 19.   Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
  2. Findlay, V. J.; Townsend, D. M.; Saavedra, J. E.; Buzard, G. S.; Citro, M. L.; Keefer, L. K.; Ji, X. H.; Tew, K. D.
  3. Molecular Pharmacology. 2004 65(5): 1070-1079.
  1. 20.   Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
  2. Willey, R. L.; Byrum, R.; Piatak, M.; Kim, Y. B.; Cho, M. W.; Rossio, J. L.; Bess, J.; Igarashi, T.; Endo, Y.; Arthur, L. O.; Lifson, J. D.; Martin, M. A.
  3. Journal of Virology. 2003 77(2): 1163-1174.
  1. 21.   Treatment of human Daudi lymphoma with anti-MUC1 antibody-targeted RNase in SCID mice
  2. Courtenay-Luck, N.; Rybak, S.; Newton, D.
  3. Blood. 2003 102(11, Part 1): 646A, Abstract 2387-646A, Abstract 2387.
  1. 22.   Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis
  2. Kullberg, M. C.; Jankovic, D.; Gorelick, P. L.; Caspar, P.; Letterio, J. J.; Cheever, A. W.; Sher, A.
  3. Journal of Experimental Medicine. 2002 196(4): 505-515.
  1. 23.   Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: A new generation of therapeutics
  2. Hursey, M.; Newton, D. L.; Hansen, H. J.; Ruby, D.; Goldenberg, D. M.; Rybak, S. M.
  3. Leukemia & Lymphoma. 2002 43(5): 953-959.
  1. 24.   Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma
  2. Huhn, M.; Sasse, S.; Tur, M. K.; Matthey, B.; Schinkothe, T.; Rybak, S. M.; Barth, S.; Engert, A.
  3. Cancer Research. 2001 61(24): 8737-8742.
  1. 25.   Helicobacter typhlonius sp nov., a novel murine urease-negative Helicobacter species
  2. Franklin, C. L.; Gorelick, P. L.; Riley, L. K.; Dewhirst, F. E.; Livingston, R. S.; Ward, J. M.; Beckwith, C. S.; Fox, J. G.
  3. Journal of Clinical Microbiology. 2001 39(11): 3920-3926.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel